GILEAD SCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q1 2010 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Gilead Sciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 1.25B shares, a 0.02% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.25B +224K +0.02% Oct 31, 2024 10-Q 2024-11-12
Q2 2024 1.24B -1.02M -0.08% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 1.25B -1.5M -0.12% Apr 30, 2024 10-Q 2024-05-08
Q3 2023 1.25B -8.2M -0.65% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 1.25B -7.35M -0.59% Jul 31, 2023 10-Q 2023-08-04
Q1 2023 1.25B -6.96M -0.56% Apr 28, 2023 10-Q 2023-05-03
Q3 2022 1.25B -140K -0.01% Oct 31, 2022 10-Q 2022-11-02
Q2 2022 1.25B -442K -0.04% Jul 29, 2022 10-Q 2022-08-08
Q1 2022 1.25B +135K +0.01% Apr 29, 2022 10-Q 2022-05-04
Q3 2021 1.25B +855K +0.07% Oct 29, 2021 10-Q 2021-11-03
Q2 2021 1.25B +85.1K +0.01% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 1.25B -195K -0.02% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 1.25B -11.6M -0.92% Oct 30, 2020 10-Q 2020-11-04
Q2 2020 1.25B -12.7M -1.01% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 1.25B -17.2M -1.35% Apr 30, 2020 10-Q 2020-05-06
Q3 2019 1.27B -28.5M -2.2% Oct 29, 2019 10-Q 2019-11-05
Q2 2019 1.27B -29.9M -2.31% Jul 30, 2019 10-Q 2019-08-06
Q1 2019 1.27B -28.7M -2.21% Apr 30, 2019 10-Q 2019-05-08
Q3 2018 1.29B -12.6M -0.97% Oct 30, 2018 10-Q 2018-11-06
Q2 2018 1.3B -9.59M -0.73% Jul 30, 2018 10-Q 2018-08-06
Q1 2018 1.3B -6.47M -0.5% Apr 30, 2018 10-Q 2018-05-09
Q3 2017 1.31B -11.2M -0.85% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 1.31B -13.7M -1.04% Jul 31, 2017 10-Q 2017-08-07
Q1 2017 1.31B -25.1M -1.88% Apr 28, 2017 10-Q 2017-05-10
Q3 2016 1.32B -124M -8.59% Oct 31, 2016 10-Q 2016-11-07
Q2 2016 1.32B -148M -10.1% Jul 31, 2016 10-Q 2016-08-05
Q1 2016 1.33B -138M -9.38% Apr 29, 2016 10-Q 2016-05-06
Q4 2015 1.37B -123M -8.23% Feb 12, 2016 10-K 2016-02-24
Q3 2015 1.44B -67.5M -4.47% Oct 30, 2015 10-Q 2015-11-04
Q2 2015 1.47B -44.1M -2.92% Jul 31, 2015 10-Q 2015-08-05
Q1 2015 1.47B -66.1M -4.3% Apr 30, 2015 10-Q 2015-05-08
Q4 2014 1.49B -48.9M -3.18% Feb 13, 2015 10-K 2015-02-25
Q3 2014 1.51B -24.7M -1.61% Oct 31, 2014 10-Q 2014-11-05
Q2 2014 1.51B -19M -1.24% Jul 25, 2014 10-Q 2014-08-04
Q1 2014 1.54B +10.3M +0.68% Apr 25, 2014 10-Q 2014-05-07
Q4 2013 1.54B Feb 14, 2014 10-K 2014-02-25
Q3 2013 1.53B +776M +102% Oct 18, 2013 10-Q 2013-10-31
Q2 2013 1.53B +774M +102% Jul 19, 2013 10-Q 2013-08-01
Q1 2013 1.53B +768M +101% Apr 26, 2013 10-Q 2013-05-08
Q3 2012 758M +6.51M +0.87% Oct 26, 2012 10-Q 2012-11-06
Q2 2012 757M -14.9M -1.93% Jul 20, 2012 10-Q 2012-08-01
Q1 2012 757M -29.7M -3.78% Apr 27, 2012 10-Q 2012-05-04
Q4 2011 757M Feb 10, 2012 10-K 2012-02-23
Q3 2011 751M -60.7M -7.48% Oct 28, 2011 10-Q 2011-11-04
Q2 2011 771M -67.2M -8.01% Jul 29, 2011 10-Q 2011-08-05
Q1 2011 787M -103M -11.6% Apr 29, 2011 10-Q 2011-05-09
Q3 2010 812M Oct 29, 2010 10-Q 2010-11-08
Q2 2010 839M Jul 31, 2010 10-Q 2010-08-09
Q1 2010 890M Apr 30, 2010 10-Q 2010-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.